摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基联苯-3-羧酸 | 168618-44-8

中文名称
2-甲基联苯-3-羧酸
中文别名
2'-甲基联苯-3-羧酸
英文名称
2'-methylbiphenyl-3-carboxylic acid
英文别名
3-(2-methylphenyl)benzoic acid
2-甲基联苯-3-羧酸化学式
CAS
168618-44-8
化学式
C14H12O2
mdl
——
分子量
212.248
InChiKey
IAZJDWZUCUHVPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2916399090
  • 危险性防范说明:
    P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:d60b9bdf30816e022f04d4665294e43e
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2’-Methylbiphenyl-3-carboxylic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2’-Methylbiphenyl-3-carboxylic acid
CAS number: 168618-44-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H12O2
Molecular weight: 212.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-甲基联苯-3-羧酸 、 4-(4-aminophenyl)-N-cyano-N'-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]piperazine-1-carboximidamide 在 1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 生成 N-[4-[4-[N-cyano-N'-[2,6-dichloro-4-(pyrrolidin-1-ylmethyl)phenyl]carbamimidoyl]piperazin-1-yl]phenyl]-3-(2-methylphenyl)benzamide
    参考文献:
    名称:
    WO2008/148851
    摘要:
    公开号:
  • 作为产物:
    描述:
    间溴苯甲酸2-甲基苯硼酸乙二胺四乙酸potassium carbonate 、 palladium dichloride 作用下, 反应 0.5h, 以84%的产率得到2-甲基联苯-3-羧酸
    参考文献:
    名称:
    Pd-EDTA是水中铃木-宫浦反应的有效催化剂
    摘要:
    PdCl 2 -EDTA络合物1是在20-100°C的水中,芳基和杂芳基卤化物与芳基(杂芳基)硼酸的Suzuki-Miyaura反应的有效催化剂。芳基碘化物和溴化物进行交叉耦合,其周转数(TON)高达97,000,周转频率(TOF)高达582,000 h -1。
    DOI:
    10.1016/j.tetlet.2005.06.085
点击查看最新优质反应信息

文献信息

  • [EN] BCR-ABL TYROSINE-KINASE LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME<br/>[FR] LIGANDS DE TYROSINE-KINASE BCR-ABL CAPABLES DE SE DIMÉRISER DANS UNE SOLUTION AQUEUSE, ET PROCÉDÉS D'UTILISATION DE CEUX-CI
    申请人:COFERON INC
    公开号:WO2015106292A1
    公开(公告)日:2015-07-16
    Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. invivo) to form a multimer (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding sites on a Bcr-Abl tyrosine kinase.
    本文描述了一种单体,当与水性介质中的另一个、两个、三个或更多其他单体接触时,能够形成生物学上有用的多聚体。在一个方面,这种单体可能能够在水性介质(例如体内)中与另一个单体结合以形成多聚体(例如二聚体)。考虑到的单体可能包括配体基团、连接元素和连接配体基团与连接元素的连接元素。在水性介质中,这些考虑到的单体可以通过每个连接元素结合在一起,因此可以同时调节一个或多个生物分子,例如,调节Bcr-Abl酪氨酸激酶上的两个或更多结合位点。
  • Design, synthesis, and biological studies of novel 3-benzamidobenzoic acid derivatives as farnesoid X receptor partial agonist
    作者:Lijun Hu、Qiang Ren、Liming Deng、Zongtao Zhou、Zongyu Cai、Bin Wang、Zheng Li
    DOI:10.1016/j.ejmech.2020.113106
    日期:2021.2
    Farnesoid X receptor (FXR), a bile acid-activated nuclear receptor, regulates the metabolism of bile acid and lipids as well as maintains the stability of internal environment. FXR was considered as a therapeutic target of liver disorders, such as drug-induced liver injury, fatty liver and cholestasis. The previous reported FXR partial agonist 6 was a suitable lead compound in terms of its high potent
    法尼醇X受体(FXR)是胆汁酸激活的核受体,调节胆汁酸和脂质的代谢,并维持内部环境的稳定性。FXR被认为是肝脏疾病(如药物性肝损伤,脂肪肝和胆汁淤积症)的治疗目标。先前报道的FXR部分激动剂6就其高强度和低分子大小而言是一种合适的先导化合物,而化合物6的对接研究则显示了一个较大的未占据的疏水口袋,这可能为结构活性关系提供了更多可能性(SAR )学习。在这项研究中,我们基于铅化合物6进行了全面的SAR和分子建模研究。所有这些努力导致鉴定出一系列新的FXR部分激动剂。在该系列中,化合物41表现出最佳的活性,并且与FXR的结合口袋有很强的相互作用。此外,化合物41通过调节FXR相关基因的表达并提高抗氧化能力,保护小鼠免受对乙酰氨基酚诱导的肝毒性。总之,这些结果表明化合物41是一种有前途的FXR部分激动剂,适合进一步研究。
  • [EN] NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS<br/>[FR] NOUVEAUX LIGANDS ETANT DES INHIBITEURS DE RECEPTEURS RAR, PROCEDE DE FABRICATION ET UTILISATION DE CEUX-CI DANS LA MEDECINE HUMAINE ET EN COSMETIQUE
    申请人:GALDERMA RES & DEV
    公开号:WO2003101928A1
    公开(公告)日:2003-12-11
    The invention relates to novel biaryl compounds corresponding to the general formula (I) below: and to the method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternatively in cosmetic compositions.
    本发明涉及下述通式(I)的新颖联芳基化合物:以及制备它们的方法,以及它们在旨在用于人类或兽医学的药物组合物中的用途,或者作为替代,在化妆品组合物中的用途。
  • A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design
    作者:Sundus Akhter、Bjarte Aarmo Lund、Aya Ismael、Manuel Langer、Johan Isaksson、Tony Christopeit、Hanna-Kirsti S. Leiros、Annette Bayer
    DOI:10.1016/j.ejmech.2017.12.085
    日期:2018.2
    β-lactamase inhibitors and today several β-lactamase inhibitors e.g. avibactam, are approved in the clinic. Our focus is the oxacillinase-48 (OXA-48), an enzyme reported to spread rapidly across the world and commonly identified in Escherichia coli and Klebsiella pneumoniae. To guide inhibitor design, we used diversely substituted 3-aryl and 3-heteroaryl benzoic acids to probe the active site of OXA-48
    当在医学界中治疗细菌感染时,β-内酰胺抗生素至关重要。然而,目前它们的效用受到β-内酰胺抗性的出现和扩散的威胁。对β-内酰胺抗生素最普遍的耐药机制是β-内酰胺酶的表达。克服由β-内酰胺酶引起的抗性的一种方法是开发β-内酰胺酶抑制剂,如今临床上已经批准了几种β-内酰胺酶抑制剂,例如阿维巴坦。我们的研究重点是oxacillinase-48(OXA-48),据报道该酶在世界范围内迅速传播,通常在大肠杆菌和肺炎克雷伯菌中得到鉴定。为了指导抑制剂的设计,我们使用了不同取代的3-芳基和3-杂芳基苯甲酸来探测OXA-48的活性位点,以进行有用的酶-抑制剂相互作用。在本研究中,合成了包含49个3-取代的苯甲酸衍生物的聚焦片段文库,并对其进行了生化表征。基于从33片段的酶复合物晶体学数据,片段可以被归类为R 1或R 2个可以通过总体结合构象相对于粘合剂到R的结合1和R 2亚胺培南的侧基。此外,发现了对未来抑
  • [EN] BROMODOMAIN LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION<br/>[FR] LIGANDS DE BROMODOMAINE POUVANT SE DIMÉRISER DANS UNE SOLUTION AQUEUSE
    申请人:COFERON INC
    公开号:WO2015081280A1
    公开(公告)日:2015-06-04
    Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding domains on a protein or on different proteins.
    本文描述的是一种单体,当与水性介质中的一个、两个、三个或更多其他单体接触时,能够形成具有生物学用途的多聚体。在一个方面,这些单体可能能够在水性介质中(例如体内)与另一个单体结合,形成一个多聚体(例如二聚体)。考虑到的单体可能包括一个配体基团、一个连接元素和连接配体基团与连接元素的连接元素。在水性介质中,这些考虑到的单体可以通过每个连接元素相互结合,因此可以同时调节一个或多个生物分子,例如,调节蛋白质上的两个或更多结合结构域或不同蛋白质上的结合结构域。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐